Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_53_библиотеки_им_акад_М_И_Перельмана
.pdf
de Moura EL, Dos Santos ACM, da Silva DM, Dos Santos BB, Figueredo DS, Moura AWA et al
(2020) Association of polymorphisms in cytokine genes with susceptibility to precancerous
lesions and cervical cancer: a systematic review with meta-analysis. Immunol Invest 30:1–35.
https://doi.org/10.1080/08820139.2020.1778023
Del Vecchio M, Bajetta E, Canova S, Lotze MT, Wesa A, Parmiani G, Anichini A (2007)
Interleukin-12: biological properties and clinical application. Clin Cancer Res 13
(16):4677–4685. https://doi.org/10.1158/1078-0432.CCR-07-0776
Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu
Rev Immunol 27:519–550
Dinarello CA (2011) A clinical perspective of IL-1beta as the gatekeeper of inflammation. Eur J
Immunol 41(5):1203–1217
Ding B, Fu S, Wang M, Yue C, Wang W, Zhou D, Zhang Z, Han S (2012) Tumor necrosis factor α
308 G>a polymorphisms and cervical cancer risk: a meta-analysis. Int J Gynecol Cancer 22
(2):213–219. https://doi.org/10.1097/IGC.0b013e3182375aed
Du GH, Wang JK, Richards JR, Wang JJ (2019) Genetic polymorphisms in tumor necrosis factor
alpha and interleukin-10 are associated with an increased risk of cervical cancer. Int
Immunopharmacol 66:154–161. https://doi.org/10.1016/j.intimp.2018.11.015
Einstein MH, Leanza S, Chiu LG, Schlecht NF, Goldberg GL, Steinberg BM, Burk RD (2009)
Genetic variants in TAP are associated with high-grade cervical neoplasia. Clin Cancer Res 15
(3):1019–1023. https://doi.org/10.1158/1078-0432.CCR-08-1207
El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J,
Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF Jr, Rabkin CS (2001)
The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature 412
(6842):99. https://doi.org/10.1038/35083631.
El-Omar EM, Ng MT, Hold GL (2008) Polymorphisms in toll like receptor genes and risk of cancer.
Oncogene 27:244–252
Engelhard VH (1994) How cells process antigens. Sci Am 271(2):54–61
Eskdale J, Kube D, Tesch H, Gallagher G (1997) Mapping of the human IL10 gene and further
characterization of the 5
0
flanking sequence. Immunogenetics 46:120–128
Evan GI, Vousden KH (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411:342–348
Faucz FR, Probst CM, Petzl-Erler ML (2000) Polymorphism of LMP2, TAP1, LMP7 and TAP2 in
Brazilian Amerindians and Caucasoids: implications for the evolution of allelic and haplotypic
diversity. Eur J Immunogenet 27(1):5–16
Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F
(2019) Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and
methods. Int J Cancer 144(8):1941–1953. https://doi.org/10.1002/ijc.31937
Fernández-Mestre M, Sánchez K, Balbás O, Gendzekhzadze K, Ogando V, Cabrera M, Layrisse Z
(2009) Influence of CTLA-4 gene polymorphism in autoimmune and infectious diseases. Hum
Immunol 70(7):532–535. https://doi.org/10.1016/j.humimm.2009.03.016
Formana D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J,
Bray F, Plummer M, Franceschi S (2012) Global burden of human papillomavirus and related
diseases. Vaccine 30S:F12–F23. https://doi.org/10.1016/j.vaccine.2012.07.055
Gao SL, Chen YD, Yue C, Chen J, Zhang LF, Wang SM, Zuo L (2019) 196 to 174del, rs4696480,
rs3804099 polymorphisms of Toll-like receptor 2 gene impact the susceptibility of cancers:
evidence from 37053 subjects. Biosci Rep 39(12):BSR20191698. https://doi.org/10.1042/
BSR20191698
Ghaderi A (2011) CTLA4 gene variants in autoimmunity and cancer: a comparative review. Iran J
Immunol 8:127–149
Gokhale P, Kerkar S, Tongaonkar H et al (2013) CTLA-4 gene polymorphism at position+49 a>G
in exon 1: a risk factor for cervical cancer in Indian women. Cancer Genet 206:154–161
Grenet J, Teitz T, Wei T, Valentine V, Kidd VJ (1999) Structure and chromosome localization of
the human CASP8 gene. Gene 226(2):225–232. https://doi.org/10.1016/s0378-1119(98)00565-
4
7 Genetic Polymorphisms of Essential Immune Pathogenic Response Genes and... 225
https://t.me/medicina_free
Groves IJ, Coleman N (2015) Pathogenesis of human papillomavirus-associated mucosal disease. J
Pathol 235(4):527–538. https://doi.org/10.1002/path.4496
Guo C, Wen L, Song JK, Zeng WJ, Dan C, Niu YM, Shen M (2018) Significant association
between interleukin-10 gene polymorphisms and cervical cancer risk: a meta-analysis.
Oncotarget 9(15):12365–12375. https://doi.org/10.18632/oncotarget.24193
Habbous S, Pang V, Eng L, Xu W, Kurtz G, Liu FF, Mackay H, Amir E, Liu G (2012) p53
Arg72Pro polymorphism, HPV status and initiation, progression, and development of cervical
cancer: a systematic review and meta-analysis. Clin Cancer Res 18(23):6407–6415. https://doi.
org/10.1158/1078-0432.CCR-12-1983
Hasan UA, Bates E, Takeshita F, Biliato A, Accardi R, Bouvard V et al (2007) TLR9 expression
and function is abolished by the cervical cancer-associated human papillomavirus type 16. J
Immunol 178:3186–3197
Hashemi M, Eskandari-Nasab E, Fazaeli A, Rezaei H, Mashhadi MA, Arbabi F, Taheri M (2012)
Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 -652 6N
ins/del promoter polymorphism (rs3834129) in breast cancer. Gene 505(1):176–179
Hashemi M, Aftabi S, Moazeni-Roodi A, Sarani H, Wiechec E, Ghavami S (2020) Association of
CASP8 polymorphisms and cancer susceptibility: a meta-analysis. Eur J Pharmacol
881:173201. https://doi.org/10.1016/j.ejphar.2020.173201
Hattori A, Tsujimoto M (2013) Endoplasmic reticulum aminopeptidases: biochemistry, physiology
and pathology. J Biochem 154(3):219–228
He B, Zhang Y, Pan Y, Xu Y, Gu L, Chen L, Wang S (2011) Interleukin 1 beta (IL1B) promoter
polymorphism and cancer risk: evidence from 47 published studies. Mutagenesis 26
(5):637–642. https://doi.org/10.1093/mutage/ger025
Hemmat N, Bannazadeh Baghi H (2019) Association of human papillomavirus infection and
inflammation in cervical cancer. Pathog Dis 77(5):ftz048. https://doi.org/10.1093/femspd/
ftz048
Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, Lush MJ, Povey S, Talbot
CC Jr, Wright MW, Wain HM, Trowsdale J, Ziegler A, Beck S (2004) Gene map of the
extended human MHC. Nat Rev Genet 5(12):889–899. https://doi.org/10.1038/nrg1489
Howell WM, Rose-Zerilli MJ (2007) Cytokine gene polymorphisms, cancer susceptibility, and
prognosis. J Nutr 137(Suppl):194s–199s
Hu X, Zhang Z, Ma D, Huettner PC, Massad LS, Nguyen L et al (2010) TP53, MDM2, NQO1, and
susceptibility to cervical cancer. Cancer Epidemiol Biomarkers Prev 19(3):755–761
Hu S, Pu D, Xia X, Guo B, Zhang C (2020) CTLA-4 rs5742909 polymorphism and cervical cancer
risk: a meta-analysis. Medicine (Baltimore) 99(11):e19433. https://doi.org/10.1097/MD.
0000000000019433
Insinga RP, Dasbach EJ, Elbasha EH (2009) Epidemiologic natural history and clinical manage-
ment of Human Papillomavirus (HPV) disease: a critical and systematic review of the literature
in the development of an HPV dynamic transmission model. BMC Infect Dis 9:119. https://doi.
org/10.1186/1471-2334-9-119.
Jiang Q, Wei H, Tian Z (2008) Poly I:C enhances cycloheximide-induced apoptosis of tumor cells
through TLR3 pathway. BMC Cancer 8:12. https://doi.org/10.1186/1471-2407-8-12
Jiang P, Liu J, Li W, Zeng X, Tang J (2011) Correlation between MDM2 gene SNP
309 polymorphisms and cervical cancer. Chin J Clin Oncol 1:1–4
Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G et al (2001) Haplotype
tagging for the identification of common disease genes. Nat Genet 29:233–237
Jung HM, Phillips BL, Chan EK (2014) miR-375 activates p21 and suppresses telomerase activity
by coordinately regulating HPV E6/E7, E6AP, CIP2A, and 14-3-3ζ. Mol Cancer 13:80. https://
doi.org/10.1186/1476-4598-13-80
Kak G, Raza M, Tiwari BK (2018) Interferon-gamma (IFN-γ): exploring its implications in
infectious diseases. Biomol Concepts 9(1):64–79. https://doi.org/10.1515/bmc-2018-0007
226 S. Nissar et al.
https://t.me/medicina_free
Kamiza AB, Kamiza S, Mathew CG (2020) HLA-DRB1 alleles and cervical cancer: a meta-analysis
of 36 case-control studies. Cancer Epidemiol 67:101748. https://doi.org/10.1016/j.canep.2020.
101748
Kanemitsu S, Ihara K, Saifddin A, Otsuka T, Takeuchi T, Nagayama J, Kuwano M, Hara T (2002)
A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus
erythematosus. J Rheumatol 29(6):1183–1188
Kang S, Kim JW, Park NH, Song YS, Park SY, Kang SB, Lee HP (2007) Interleukin-1 beta-511
polymorphism and risk of cervical cancer. J Korean Med Sci 22(1):110–113. https://doi.org/10.
3346/jkms.2007.22.1.110
Kashyap N, Krishnan N, Kaur S, Ghai S (2019) Risk factors of cervical cancer: a case-control study.
Asia Pac J Oncol Nurs 6(3):308–314. https://doi.org/10.4103/apjon.apjon_73_18
Kim JW, Roh JW, Park NH, Song YS, Kang SB, Lee HP (2003) Interferon, alpha 17 (IFNA17)
Ile184Arg polymorphism and cervical cancer risk. Cancer Lett 189:183–188
Klein J, Sato A (2000) The HLA system. First of two parts. N Engl J Med 343:702–709
Kordi Tamandani DM, Sobti RC, Shekari M, Husseini SA, Suri V (2009) No association of TAP1
and TAP2 genes polymorphism with risk of cervical cancer in north Indian population. J Assist
Reprod Genet 26(4):173–178. https://doi.org/10.1007/s10815-009-9301-2
Kutikhin AG (2011) Association of polymorphisms in TLR genes and in genes of the toll-like
receptor signaling pathway with cancer risk. Hum Immunol 72:1095–1116
Lai HC, Sytwu HK, Sun CA, YuMH YCP, Liu HS et al (2003) Single nucleotide polymorphism at
Fas promoter is associated with cervical carcinogenesis. Int J Cancer 103(2):221–225
Lai HC, Lin WY, Lin YW, Chang CC, Yu MH, Chen CC et al (2005) Genetic polymorphisms of
FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: an analysis of haplotype and
gene-gene interaction. Gynecol Oncol 99(1):113–118
Lankat-Buttgereit B, Tampé R (2002) The transporter associated with antigen processing: function
and implications in human diseases. Physiol Rev 82(1):187–204. https://doi.org/10.1152/
physrev.00025.2001
Lee YH, Song GG (2014) A meta-analysis of the association between CTLA-4 +49 A/G, 318
C/T, and IL-1 polymorphisms and susceptibility to cervical cancer. Neoplasma 61(4):481–490.
https://doi.org/10.4149/neo_2014_060
Leone P, Shin EC, Perosa F, Vacca A, Dammacco F, Racanelli V (2013) MHC class I antigen
processing and presenting machinery: organization, function, and defects in tumor cells. J Natl
Cancer Inst 105(16):1172–1187. https://doi.org/10.1093/jnci/djt184
Li M, Han Y, Wu TT, Feng Y, Wang HB (2013) Tumor necrosis factor alpha rs1800629
polymorphism and risk of cervical lesions: a meta-analysis. PLoS One 8(8):e69201. https://
doi.org/10.1371/journal.pone.0069201
Li C, Li Y, Yan Z, Dai S, Liu S, Wang X, Wang J, Zhang X, Shi L, Yao Y (2020) Polymorphisms in
endoplasmic reticulum aminopeptidase genes are associated with cervical cancer risk in a
Chinese Han population. BMC Cancer 20(1):341. https://doi.org/10.1186/s12885-020-06832-2.
Liu L, Yang X, Chen X, Kan T, Shen Y, Chen Z, Hu Z (2012) Association between TNF-α
polymorphisms and cervical cancer risk: a meta-analysis. Mol Biol Rep 39(3):2683–2688.
https://doi.org/10.1007/s11033-011-1022-9
Liu N, Song Y, Shi W (2015) IFN-γ +874 T/a polymorphisms contributes to cervical cancer
susceptibility: a meta-analysis. Int J Clin Exp Med 8(3):4008–4015
Liu S, Cao D, Shen Y, Li Y, Li Y, Shi L, Yu J, Li C, Zhang X, Sun M, Yao Y (2017) The ERAP
gene is associated with HCV chronic infection in a Chinese Han population. Hum Immunol 78
(11–12):731–738
Long H, O'Connor BP, Zemans RL, Zhou X, Yang IV, Schwartz DA (2014) The toll-like receptor
4 polymorphism Asp299Gly but not Thr399Ile influences TLR4 signaling and function. PLoS
One 9(4):e93550. https://doi.org/10.1371/journal.pone.0093550
Lorenz E, Frees KL, Schwartz DA (2001) Determination of the TLR4 genotype using allele-specific
PCR. Biotechniques 31:22–
24
Lowe SW, Lin AW (2000) Apoptosis in cancer. Carcinogenesis 21:485– 495
7 Genetic Polymorphisms of Essential Immune Pathogenic Response Genes and... 227
https://t.me/medicina_free
Ma X, Yang C, Tang R, Xu Z, Zhang Z, Wang Y, Zhang J, Yang LI (2015) Association between
LMP2 and LMP7 gene polymorphisms and the risk of gastric cancer: a case-control study.
Oncol Lett 10(1):509–517
Mandal RK, Dar SA, Jawed A, Wahid M, Lohani M, Panda AK, Mishra BN, Akhter N, Areeshi
MY, Haque S (2017) Impact of LMP7 (rs2071543) gene polymorphism in increasing cancer
risk: evidence from a meta-analysis and trial sequential analysis. Oncotarget 9(5):6572–6585.
https://doi.org/10.18632/oncotarget.23547
Martínez-Campos C, Torres-Poveda K, Camorlinga-Ponce M, Flores-Luna L, Maldonado-Bernal C,
Madrid-Marina V, Torres J (2019) Polymorphisms in IL-10 and TGF-β gene promoter are
associated with lower risk to gastric cancer in a Mexican population. BMC Cancer 19(1):453.
https://doi.org/10.1186/s12885-019-5627-z
Maskoen AM, Susanto H, Surialaga S, Sahiratmadja E (2013) IFNG polymorphism (+874 T>a) is
not a risk factor for cervical cancer. Univ Med 32:29–36
McIlwain DR, Berger T, Mak TW (2013) Caspase functions in cell death and disease. Cold Spring
Harb Perspect Biol 5(4):a008656. https://doi.org/10.1101/cshperspect.a008656. Erratum in:
Cold Spring Harb Perspect Biol. 2015 Apr;7(4). pii: a026716
McIlwain DR, Berger T, Mak TW (2015) Caspase functions in cell death and disease. Cold Spring
Harb Perspect Biol 7(4):a026716. https://doi.org/10.1101/cshperspect.a026716. Erratum for:
Cold Spring Harb Perspect Biol. 2013 Apr;5(4):a008656
Mehta AM, Jordanova ES, van Wezel T, Uh HW, Corver WE, Kwappenberg KM, Verduijn W,
Kenter GG, van der Burg SH, Fleuren GJ (2007) Genetic variation of antigen processing
machinery components and association with cervical carcinoma. Genes Chromosomes Cancer
46(6):577–586
Mehta AM, Spaans VM, Mahendra NB, Osse EM, Vet JN, Purwoto G, Surya IG, Cornian S, Peters
AA, Fleuren GJ, Jordanova ES (2015) Differences in genetic variation in antigen-processing
machinery components and association with cervical carcinoma risk in two Indonesian
populations. Immunogenetics 67:267–275
Mehta AM, Mooij M, Branković I, Ouburg S, Morré SA, Cervical Carcinogenesis JES (2017a)
Immune response gene polymorphisms: a review. J Immunol Res 2017:8913860. https://doi.
org/10.1155/2017/8913860.
Mehta AM, Mooij M, Branković I, Ouburg S, Morré SA, Jordanova ES (2017b) Cervical carcino-
genesis and immune response gene polymorphisms: a review. J Immunol Res 2017:8913860.
https://doi.org/10.1155/2017/8913860
Mogensen TH (2009) Pathogen recognition and inflammatory signaling in innate immune defenses.
Clin Microbiol Rev 22:240–273
Monaco JJ (1992) A molecular model of MHC class-I-restricted antigen processing. Immunol
Today 13(5):173–179. https://doi.org/10.1016/0167-5699(92)90122-N
Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A (2001) Interleukin-10 and the interleukin-
10 receptor. Annu Rev Immunol 19:683–765
Mosaad YM, Metwally SS, Farag RE, Lotfy ZF, AbdelTwab HE (2019) Association between toll-
like receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and chronic HCV.
Immunol Invest 48(3):321–332. https://doi.org/10.1080/08820139.2018.1527851
Moscicki AB, Ma Y, Wibbelsman C, Darragh TM, Powers A, Farhat S, Shiboski S (2010) Rate of
and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women.
Obstet Gynecol 116(6):1373–1380. https://doi.org/10.1097/AOG.0b013e3181fe777f
Munoz N, Bosch FX, de Sanjose S et al (2003) Epidemiologic classification of human papilloma-
virus types associated with cervical cancer. N Engl J Med 348:518–527
Murphy ME (2006) Polymorphic variants in the p53 pathway. Cell Death Differ 13(6):916–920
Nagata S (1997) Apoptosis by death factor. Cell 88(3):355–365. https://doi.org/10.1016/s0092-
8674(00)81874-7
Narisawa-Saito M, Kiyono T (2007) Basic mechanisms of high-risk human papillomavirus-induced
carcinogenesis: roles of E6 and E7 proteins. Cancer Sci 98(10):1505–1511. https://doi.org/10.
1111/j.1349-7006.2007.00546.x
228 S. Nissar et al.
https://t.me/medicina_free
National Cancer Institute (2020) Definitions. https://www.cancer.gov/publications/dictionaries/
cancer-terms/expand/C. Accessed 24 July 2020
Natter C, Polterauer S, Rahhal-Schupp J, Cacsire Castillo-Tong D, Pils S, Speiser P, Zeillinger R,
Heinze G, Grimm C (2013) Association of TAP gene polymorphisms and risk of cervical
intraepithelial neoplasia. Dis Markers 35(2):79–84. https://doi.org/10.1155/2013/368732
Neefjes J, Jongsma ML, Paul P, Bakke O (2011) Towards a systems understanding of MHC class I
and MHC class II antigen presentation. Nat Rev Immunol 11(12):823–836
Ni J, Ye Y, Teng F, Wu Q (2013) Interleukin 10 polymorphisms and cervical cancer risk: a meta-
analysis. Int J Gynecol Cancer 23:126–133
Nischalke HD, Coenen M, Berger C, Aldenhoff K, Müller T, Berg T, Krämer B, Körner C,
Odenthal M, Schulze F, Grünhage F, Nattermann J, Sauerbruch T, Spengler U (2012) The
toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and suscepti-
bility to hepatocellular carcinoma in chronic hepatitis C. Int J Cancer 130(6):1470–1475. https://
doi.org/10.1002/ijc.26143
Nunobiki O, Ueda M, Yamamoto M, Toji E, Sato N, Izuma S et al (2010) MDM2 SNP 309 human
papillomavirus infection in cervical carcinogenesis. Gynecol Oncol 118(3):258–261
Nunobiki O, Ueda M, Toji E, Yamamoto M, Akashi K, Sato N, Izuma S, Torii K, Tanaka I,
Okamoto Y, Noda S (2011) Genetic polymorphism of cancer susceptibility genes and HPV
Infection in cervical carcinogenesis. Patholog Res Int 2011:364069. https://doi.org/10.4061/
2011/364069
Ortiz GJ, Li Y, Post SM, Pant V, Xiong S, Larsson CA, El-Naggar AK, Johnson DG, Lozano G
(2018) Contrasting effects of an Mdm2 functional polymorphism on tumor phenotypes. Onco-
gene 37(3):332–340. https://doi.org/10.1038/onc.2017.344
Ouma C, Davenport GC, Were T, Otieno MF, Hittner JB, Vulule JM, Martinson J, Ong’echa JM,
Ferrell RE, Perkins DJ (2008) Haplotypes of IL-10 promoter variants are associated with
susceptibility to severe malarial anemia and functional changes in IL-10 production. Hum
Genet 124:515–524
Paladini F, Fiorillo MT, Vitulano C, Tedeschi V, Piga M, Cauli A, Mathieu A, Sorrentino R (2018)
An allelic variant in the intergenic region between ERAP1 and ERAP2 correlates with an
inverse expression of the two genes. Sci Rep 8(1):10398. https://doi.org/10.1038/s41598-018-
28799-8
Pan F, Tian J, Ji CS, He YF, Han XH, Wang Y, Du JP, Jiang FS, Zhang Y, Pan YY, Hu B (2012)
Association of TNF-α-308 and -238 polymorphisms with risk of cervical cancer: a meta-
analysis. Asian Pac J Cancer Prev 13(11):5777–5783. https://doi.org/10.7314/apjcp.2012.13.
11.5777
Pandey S, Mittal RD, Srivastava M, Srivastava K, Singh S, Srivastava S, Mittal B (2009) Impact of
toll-like receptors [TLR] 2 (196 to 174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical
cancer susceptibility in north Indian women. Gynecol Oncol 114:501–505
Pandey S, Mittal B, Srivastava M, Singh S, Srivastava K, Lal P, Mittal RD (2011) Evaluation of
toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer
susceptibility. Mol Biol Rep 38(7):4715–4721. https://doi.org/10.1007/s11033-010-0607-z
Pandey NO, Chauhan AV, Raithatha NS, Patel PK, Khandelwal R, Desai AN, Choxi Y, Kapadia
RS, Jain ND (2019) Association of TLR4 and TLR9 polymorphisms and haplotypes with
cervical cancer susceptibility. Sci Rep 9(1):9729. https://doi.org/10.1038/s41598-019-46077-
z. Erratum in: Sci Rep. 2019 Dec 4;9(1):18658
Pawlak E, Kochanowska IE, Frydecka I, Kiełbiński M, Potoczek S, Bilińska M et al (2005) The
soluble CTLA-4 receptor: a new marker in autoimmune diseases. Arch Immunol Ther Exp
(Warsz) 53:336–341
Pietsch EC, Humbey O, Murphy ME (2006) Polymorphisms in the p53 pathway. Oncogene 25
(11):1602–1611. https://doi.org/10.1038/sj.onc.1209367
Praest P, Luteijn RD, Brak-Boer IGJ, Lanfermeijer J, Hoelen H, Ijgosse L, Costa AI, Gorham RDJ,
Lebbink RJ, Wiertz EJHJ (2018) The influence of TAP1 and TAP2 gene polymorphisms on
7 Genetic Polymorphisms of Essential Immune Pathogenic Response Genes and... 229
https://t.me/medicina_free
TAP function and its inhibition by viral immune evasion proteins. Mol Immunol 101:55–64.
https://doi.org/10.1016/j.molimm.2018.05.025
Raabe T, Bukrinsky M, Currie RA (1998) Relative contribution of transcription and translation to
the induction of tumor necrosis factor-alpha by lipopolysaccharide. J Biol Chem 273
(2):974–980. https://doi.org/10.1074/jbc.273.2.974
Rabinowich H, Reichert TE, Kashii Y, Gastman BR, Bell MC, Whiteside TL (1998) Lymphocyte
apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered
expression of T cell receptor in tumor-associated lymphocytes. J Clin Invest 101
(11):2579–2588. https://doi.org/10.1172/JCI1518
Roszak A, Lianeri M, Sowińska A, Jagodziński PP (2012) Involvement of toll-like receptor
9 polymorphism in cervical cancer development. Mol Biol Rep 39(8):8425–8430. https://doi.
org/10.1007/s11033-012-1695-8
Saadatzadeh MR, Elmi AN, Pandya PH, Bijangi-Vishehsaraei K, Ding J, Stamatkin CW, Cohen-
Gadol AA, Pollok KE (2017) The role of MDM2 in promoting genome stability versus
instability. Int J Mol Sci 18(10):2216. https://doi.org/10.3390/ijms18102216
Saleh M, Virarkar M, Javadi S, Elsherif SB, de Castro Faria S, Bhosale P (2020) Cervical cancer:
2018 revised international federation of gynecology and obstetrics staging system and the role of
imaging. AJR Am J Roentgenol 214(5):1182–1195. https://doi.org/10.2214/AJR.19.21819
Salib MY, Russell JHB, Stewart VR, Sudderuddin SA, Barwick TD, Rockall AG, Bharwani N
(2020) 2018 FIGO staging classification for cervical cancer: added benefits of imaging.
Radiographics 40(6):1807–1822. https://doi.org/10.1148/rg.2020200013
Saulle I, Vicentini C, Clerici M, Biasin M (2020) An overview on ERAP roles in infectious
diseases. Cell 9(3):720. https://doi.org/10.3390/cells9030720
Saveanu L, Carroll O, Lindo V, Del Val M, Lopez D, Lepelletier Y, Greer F, Schomburg L, Fruci D,
Niedermann G, van Endert PM (2005) Concerted peptide trimming by human ERAP1 and
ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat Immunol 6(7):689–697
Sawhney R, Visvanathan K (2011) Polymorphisms of toll-like receptors and their pathways in viral
hepatitis. Antivir Ther 16(4):443–458. https://doi.org/10.3851/IMP1820
Schena FP, Cerullo G, Torres DD, Scolari F, Foramitti M, Amoroso A et al (2006) Role of
interferon-γ gene polymorphisms in susceptibility to IgA nephropathy: a family-based associa-
tion study. Eur J Hum Genet 14:488–496
Schroder K, Hertzog PJ, Ravasi T, Hume DA (2004) Interferon-gamma: an overview of signals,
mechanisms and functions. J Leukoc Biol 75(2):163–189. https://doi.org/10.1189/jlb.0603252
Schultz DR, Harrington WJ Jr (2003) Apoptosis: programmed cell death at a molecular level. Semin
Arthritis Rheum 32(6):345–369. https://doi.org/10.1053/sarh.2003.50005
Schumacher TN, Kantesaria DV, Heemels MT, shton-Rickardt PG, Shepherd JC, Fruh K et al
(1994) Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator. J Exp
Med 179:533–540
Schwabe RF, Brenner DA (2006) Mechanisms of liver injury. I. TNF-alpha-induced liver injury:
role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol 290(4):G583–
G589. https://doi.org/10.1152/ajpgi.00422.2005
Serwold T, Gaw S, Shastri N (2001) ER aminopeptidases generate a unique pool of peptides for
MHC class I molecules. Nat Immunol 2(7):644–651
Shen J, Sun NX (2013) Association between FAS A670G polymorphism and susceptibility to
cervical cancer: evidence from a meta-analysis. Tumour Biol 34(6):3443–3448. https://doi.org/
10.1007/s13277-013-0920-y
Sibley K, Rollinson S, Allan JM, Smith AG, Law GR, Roddam PL et al (2003) Functional FAS
promoter polymorphisms are associated with increased risk of acute myeloid leukemia. Cancer
Res 63(15):4327–4330
Singhal P, Hussain S, Thakur N, Batra S, Salhan S, Bhambani S et al (2013) Association of MDM2
and p53 polymorphisms with the advancement of cervical carcinoma. DNA Cell Biol 32
(1):19–27
230 S. Nissar et al.
https://t.me/medicina_free
Song L, Ma N, Han L, Yan H, Yan B, Yuan Z, Cao B (2014) Association between LMP2/LMP7
genetic variability and the metastasis risk of ovarian cancer in Chinese women in Beijing. Hum
Immunol 75:239–244
Sousa H, Santos AM, Pinto D (2011) Medeiros R. is there a biological plausability for p53 codon
72 polymorphism influence on cervical cancer development? Acta Med Port 24(1):127–134
Stanczuk GA, Sibanda EN, Perrey C, Chirara M, Pravica V, Hutchinson IV, Tswana SA (2001)
Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding
for increased IL-10 production. Int J Cancer 94:792–794
Stanley M (2010) Pathology and epidemiology of HPV infection in females. Gynecol Oncol
117:5–10
Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD (1998) How cells respond to
interferons. Annu Rev Biochem 67:227–264
Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F et al (1998) Role of a p53
polymorphism in the development of human papillomavirus-associated cancer. Nature 393
(6682):229–234
Stratikos E, Stamogiannos A, Zervoudi E, Fruci D (2014) A role for naturally occurring alleles of
endoplasmic reticulum aminopeptidases in tumor immunity and cancer pre-disposition. Front
Oncol 4:363
Su TH, Chang TY, Lee YJ, Chen CK, Liu HF (2007) CTLA-4 gene and susceptibility to human
papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women. Carcino-
genesis 28:1237–1240
Sun T, Gao Y, Tan W, Ma S, Shi Y, Yao J, Guo Y, Yang M, Zhang X, Zhang Q, Zeng C, Lin D
(2007) A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated
with susceptibility to multiple cancers. Nat Genet 39:605–613
Sun L, Cornell TT, LeVine A, Berlin AA, Hinkovska-Galcheva V, Fleszar AJ, Lukacs NW,
Shanley TP (2013) Dual role of interleukin-10 in the regulation of respiratory syncytial virus
(RSV)-induced lung inflammation. Clin Exp Immunol 172:263–279
Sun R, Jia F, Liang Y, Li L, Bai P, Yuan F, Gao L, Zhang L (2015a) Interaction analysis of IL-12A
and IL-12B polymorphisms with the risk of colorectal cancer. Tumour Biol 36:9295–9301
Sun Y, Lu Y, Pen Q, Li T, Xie L, Deng Y, Qin A (2015b) Interferon gamma +874 T/a polymor-
phism increases the risk of cervical cancer: evidence from a meta-analysis. Tumour Biol 36
(6):4555–4564. https://doi.org/10.1007/s13277-015-3100-4
Tan SC, Ankathil R (2015) Genetic susceptibility to cervical cancer: role of common
polymorphisms in apoptosis-related genes. Tumour Biol 36(9):6633–6644. https://doi.org/10.
1007/s13277-015-3868-2
Tan A, Gao Y, Yao Z, Su S, Jiang Y, Xie Y, Xian X, Mo Z (2016) Genetic variants in IL12
influence both hepatitis B virus clearance and HBV-related hepatocellular carcinoma develop-
ment in a Chinese male population. Tumour Biol 37:6343–6348
Tjalma WA, Arbyn M, Paavonen J, van Waes TR, Bogers JJ (2004) Prophylactic human papillo-
mavirus vaccines: the beginning of the end of cervical cancer. Int J Gynecol Cancer 14
(5):751–761
Trinchieri G, Pflanz S, Kastelein RA (2003) The IL-12 family of heterodimeric cytokines: new
players in the regulation of T cell responses. Immunity 19:641–644
Tsikouras P, Zervoudis S, Manav B, Tomara E, Iatrakis G, Romanidis C, Bothou A, Galazios G
(2016) Cervical cancer: screening, diagnosis and staging. J BUON 21(2):320–325
Tulay P, Serakinci N (2016) The role of human papillomaviruses in cancer progression. J Cancer
Metasta Treat 2:201–213
Ueda H, Howson JM, Esposito L, Heward J, Snook H (2003) Association of the T-cell regulatory
gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506–511
Vermeulen K, Van Bockstaele DR, Berneman ZN (2005) Apoptosis: mechanisms and relevance in
cancer. Ann Hematol 84(10):627–639. https://doi.org/10.1007/s00277-005-1065-x
Wagh P, Kulkarni P, Kerkar S, Warke H, Chaudhari H, Deodhar K, Rekhi B, Tongaonkar H,
Mania-Pramanik J (2018) Polymorphisms in cytotoxic T-lymphocyte associated antigen 4 gene
7 Genetic Polymorphisms of Essential Immune Pathogenic Response Genes and... 231
https://t.me/medicina_free
does not affect cytotoxic T-lymphocyte associated antigen 4 levels in human papillomavirus-
infected women with or without cervical cancer. Indian J Med Microbiol 36:207–210
Wang XB, Zhao X, Giscombe R, Lefvert AK (2002) A CTLA-4 gene polymorphism at position
318 in the promoter region affects the expression of protein. Genes Immun 3(4):233–234.
https://doi.org/10.1038/sj.gene.6363869
Wang RF, Miyahara Y, Wang HY (2008) Toll-like receptors and immune regulation: implications
for cancer therapy. Oncogene 27(2):181–189. https://doi.org/10.1038/sj.onc.1210906
Wang Q, Zhang C, Walayat S, Chen HW, Wang Y (2011) Association between cytokine gene
polymorphisms and cervical cancer in a Chinese population. Eur J Obstet Gynecol Reprod Biol
158:330–333. https://doi.org/10.1016/j.ejogrb.2011.05.019
Wang GQ, Bao L, Zhao XX, Zhang J, Nan KJ (2014) Associations between Fas/FasL
polymorphisms and susceptibility to cervical cancer: a meta-analysis. Tumour Biol 35
(5):4107–4112. https://doi.org/10.1007/s13277-013-1537-x
Wang P, Wang J, Yu M, Li Z (2016) Tumor necrosis factor-α T-857C (rs1799724) polymorphism
and risk of cancers: a meta-analysis. Dis Markers 2016:4580323. https://doi.org/10.1155/2016/
4580323
Wang Y, Yang J, Huang J, Tian Z (2020) Tumor necrosis factor-α polymorphisms and Cervical
cancer: evidence from a meta-analysis. Gynecol Obstet Invest 85(2):153–158. https://doi.org/
10.1159/000502955
Wei LZ, Wang HL, Liu X, Lu YP, Xu F, Yuan JQ, Ling YQ (2014) Meta-analysis on the
relationship between HLA-DRBl gene polymorphism and cervical cancer in Chinese popula-
tion. PLoS One 9(2):e88439. https://doi.org/10.1371/journal.pone.0088439
Werling D, Jungi TW (2003) TOLL-like receptors linking innate and adaptive immune response.
Vet Immunol Immunopathol 91:1):1–1)12. https://doi.org/10.1016/s0165-2427(02)00228-3
Whibley C, Pharoah PD, Hollstein M (2009) p53 polymorphisms: cancer implications. Nat Rev
Cancer 9(2):95–107. https://doi.org/10.1038/nrc2584
WHO (2020) Human papillomavirus (HPV) and cervical cancer. https://www.who.int/news-room/
fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer. Accessed 6 Apr 2020
Wing K, Yamaguchi T, Sakaguchi S (2011) Cell-autonomous and -nonautonomous roles of CTLA-
4 in immune regulation. Trends Immunol 32:428–433
Woodman JP, Dimier IH, Bout DT (1991) Human endothelial cells are activated by IFN-gamma to
inhibit toxoplasma gondii replication. Inhibition is due to a different mechanism from that
existing in mouse macrophages and human fibroblasts. J Immunol 147:2019–2023
Wu Y, Liu DF, Zhang JJ, Li X, Lu ZP, Shi GD, Yuan H, Ge YG, Wu PF, Wang Y, Jiang KR, Miao
Y (2017) Association between LMP2/LMP7 genetic variability and cancer susceptibility,
especially among Asians: evidence from a meta-analysis. Oncotarget 8(37):62445–62453.
https://doi.org/10.18632/oncotarget.18752
Xu J, Yin Z, Cao S, Gao W, Liu L, Yin Y, Liu P, Shu Y (2013) Systematic review and meta-analysis
on the association between IL-1B polymorphisms and cancer risk. PLoS One 8(5):e63654.
https://doi.org/10.1371/journal.pone.0063654
Xu Y, He B, Li R, Pan Y, Gao T, Deng Q, Sun H, Song G, Wang S (2014) Association of the
polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review
and meta-analysis of 52 studies. PLoS One 9(3):e90090. https://doi.org/10.1371/journal.pone.
0090090
Xu HH, Yan WH, Lin A (2020) The role of HLA-G in human papillomavirus infections and
cervical carcinogenesis. Front Immunol 11:1349. https://doi.org/10.3389/fimmu.2020.01349
Yang X, Wang XX, Qiu MT, Hu JW, Yin R, Xu L, Zhang Q (2013) Lack of association of three
common polymorphisms in toll-like receptors (TLRs), TLR2+597T>C, +1350C>T and
Arg753Gln with cancer risk: a meta-analysis. Asian Pac J Cancer Prev 14(10):5871–5876.
https://doi.org/10.7314/apjcp.2013.14.10.5871
Yang X, Cheng Y, Li C (2017) The role of TLRs in cervical cancer with HPV infection: a review.
Signal Transduct Target Ther 2:17055. https://doi.org/10.1038/sigtrans.2017.55
232 S. Nissar et al.
https://t.me/medicina_free
Yewdell JW (2001) Not such a dismal science: the economics of protein synthesis, folding,
degradation and antigen processing. Trends Cell Biol 11:294–297
Zhang S, Kong YL, Li YL, Yin YW (2014a) Interleukin-10 gene 1082 G/A polymorphism in
cervical cancer and cervical intraepithelial neoplasia: meta-analysis. J Int Med Res
42:1193–1201
Zhang X, Zhang L, Tian C, Yang L, Wang Z (2014b) Genetic variants and risk of cervical cancer:
epidemiological evidence, meta-analysis and research review. BJOG 121(6):664–674. https://
doi.org/10.1111/1471-0528.12638
Zhang X, Lv Z, Yu H, Wang F, Zhu J (2015) The HLA-DQB1 gene polymorphisms associated with
cervical cancer risk: a meta-analysis. Biomed Pharmacother 73:58–64. https://doi.org/10.1016/j.
biopha.2015.06.002
Zhang J, Zhang Y, Zhang Z (2018) Association of rs2279744 and rs117039649 promoter polymor-
phism with the risk of gynecological cancer: a meta-analysis of case-control studies. Medicine
(Baltimore) 97(2):e9554. https://doi.org/10.1097/MD.0000000000009554.
Zheng Y, Wang M, Tian T, Liu K, Liu X, Zhai Y, Lin S, Yang P, Li S, Dai Z, Lu J (2017) Role of
interleukin-12 gene polymorphisms in the onset risk of cancer: a meta-analysis. Oncotarget 8
(18):29795–29807. https://doi.org/10.18632/oncotarget.16080
Zhou L, Yao F, Luan H, Wang Y, Dong X, Zhou W, Wang Q (2012a) Functional polymorphisms in
the interleukin-12 gene contribute to cancer risk: evidence from a meta-analysis of 18 case-
control studies. Gene 510(1):71–77. https://doi.org/10.1016/j.gene.2012.08.019.
Zhou X, Gu Y, Zhang SL (2012b) Association between p53 codon 72 polymorphism and cervical
cancer risk among Asians: a HuGE review and meta-analysis. Asian Pac J Cancer Prev 13
(10):4909–4914. https://doi.org/10.7314/apjcp.2012.13.10.4909
Zhu J, Lu L, Cheng X, Xie R, Chen Z, Li Y et al (2014) Association between CD95L polymorphism
and cervical cancer risk: evidence from a meta-analysis. Tumour Biol 35(6):5137–5142
Zhuo X, Ren J, Li D, Wu Y, Zhou Q (2014) MDM2 SNP309 variation increases cervical cancer risk
among Asians. Tumour Biol 35(6):5331–5337
Zidi S, Verdi H, Yilmaz-Yalcin Y, Yazici AC, Gazouani E, Mezlini A, Atac FB, Yacoubi-Loueslati
B (2014) Involvement of toll-like receptors in cervical cancer susceptibility among Tunisian
women. Bull Cancer 101(10):E31–E35. https://doi.org/10.1684/bdc.2014.2037
Zidi S, Sghaier I, Gazouani E, Mezlini A, Yacoubi-Loueslati B (2016) Evaluation of toll-like
receptors 2/3/4/9 gene polymorphisms in cervical cancer evolution. Pathol Oncol Res 22
(2):323–330. https://doi.org/10.1007/s12253-015-0009-6
Zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat
Rev Cancer 2(5):342–350. https://doi.org/10.1038/nrc798
7 Genetic Polymorphisms of Essential Immune Pathogenic Response Genes and... 233
https://t.me/medicina_free
Thyroid Cancer and SNPs
8
Mosin S. Khan and Syed Mudassar
Abstract
Thyroid cancer (TC) is the most common endocrine malignancy especially in
women with papillary thyroid carcinoma (PTC) being the most prevalent type of
endocrine cancer whose incidence is growing. Despite the favorable outcome and
long survival rates of most patients, some tumors display an aggressive behavior
and may progress to the highly aggressive and lethal, anaplastic thyroid carci-
noma. In recent years, several progresses have been made on the molecular
characterization of TC. The large number of single nucleotide polymorphism
(SNP) markers available in the public databases makes studies of association and
fine mapping of disease loci very practical. In this chapter we have summarized
the genetic characterization of TC, giving a particular emphasis to SNPs, their
diagnostic importance in the risk stratification of TC and their therapeutic value.
Keywords
TC · Genes · PTC · FTC · Polymorphism · HRAS · RET · Cancer genetics
M. S. Khan (*)
Department of Biochemistry, Government Medical College Srinagar & Associated Hospitals,
Srinagar, Jammu and Kashmir, India
Department of Clinical Biochemistry, Sher-I-Kashmir Institute of Medical Sciences (SKIMS),
Srinagar, Kashmir, India
S. Mudassar
Department of Clinical Biochemistry, Sher-I-Kashmir Institute of Medical Sciences (SKIMS),
Srinagar, Kashmir, India
#
The Author(s), under exclusive license to Springer Nature Singapore Pte
Ltd. 2021
A. S. Sameer et al. (eds.), Genetic Polymorphism and Cancer Susceptibility,
https://doi.org/10.1007/978-981-33-6699-2_8
235
https://t.me/medicina_free
Соседние файлы в папке Библиотека им академика М.И. Перельмана